Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sheahan

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Techniques in Coloproctology|February 15, 2013
Management of colorectal cancer in patients with inflammatory bowel diseaseD O Kavanagh, M C Carter, D Keegan, et al.
British Journal of Cancer|July 25, 2014
Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressiveA O'Toole, A J Michielsen, B Nolan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 3, 2016
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancerH M Mohan, E Ryan, I Balasubramanian, et al.
Gut|January 18, 2015
Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteersA Lavelle, G Lennon, O O'Sullivan, et al.
Human Pathology|November 22, 2020
Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus surveyG Saliba, S Detlefsen, F Carneiro, et al.
BJS Open|December 5, 2018
Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancerÉ J Ryan, B Creavin, Y L Khaw, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Techniques in Coloproctology|February 15, 2013
Management of colorectal cancer in patients with inflammatory bowel diseaseD O Kavanagh, M C Carter, D Keegan, et al.
British Journal of Cancer|July 25, 2014
Tumour microenvironment of both early- and late-stage colorectal cancer is equally immunosuppressiveA O'Toole, A J Michielsen, B Nolan, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 3, 2016
Microsatellite instability is associated with reduced disease specific survival in stage III colon cancerH M Mohan, E Ryan, I Balasubramanian, et al.
Gut|January 18, 2015
Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteersA Lavelle, G Lennon, O O'Sullivan, et al.
Human Pathology|November 22, 2020
Tumor regression grading after neoadjuvant treatment of esophageal and gastroesophageal junction adenocarcinoma: results of an international Delphi consensus surveyG Saliba, S Detlefsen, F Carneiro, et al.
BJS Open|December 5, 2018
Effects of CDX2 on prognosis and chemotherapy responsiveness in mismatch repair-deficient colorectal cancerÉ J Ryan, B Creavin, Y L Khaw, et al.
JCO Precision Oncology|August 9, 2018
Transcriptional subtyping and CD8 immunohistochemistry identifies poor prognosis stage II/III colorectal cancer patients who benefit from adjuvant chemotherapyW L Allen, P D Dunne, S McDade, et al.
Pageof 9